Company Overview

Development Stage

About the Company

东阳光集团(深圳市东阳光实业发展有限公司)全国现共有员工近30000人;已拥有东阳光、香港东阳光药两家上市公司,正在积极筹建科创板的上市;产业多元化,以医药、电子材料和健康养生三大产业为主,2018年工业总产值近400亿元;在国内拥有广东东莞、广东乳源、湖北宜昌、西藏林芝、贵州遵义、内蒙古乌兰察布六大基地;销售公司拥有药连锁公司、大健康连锁公司、电子商务、销售业务部、海外销售部、泰合保销六大销售平台;2005年成立了研究院,现有近2400研发人员;是一个充满希望与活力、正在铸就百年基业的高科技大型股份制企业。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

How Fast Is Hiring Growing? (161 open positions)

Manage
Note: How fast is hiring at 东莞东阳光药物研发有限公司 growing? 2025: 258 openings (up 2767%), 2024: 9 openings (down 91%), 2023: 100 openings (up 2%), 2022: 98 openings (up 238%), 2021: 29 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Master's Degree Job Demand Analysis

(More)
How fast is master's hiring at 东莞东阳光药物研发有限公司 growing? Master's recruitment over the years: 2025: 30 openings (up 1400%), 2024: 2 openings (down 92%), 2023: 26 openings (down 4%), 2022: 27 openings (up 1250%), 2021: 2 openings.

Doctoral Degree Job Demand Analysis

(More)
+129%
Growth Rate
2026 vs 2025
Doctoral Hiring by Year: 2026 — 9 more jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at 东莞东阳光药物研发有限公司 growing? Doctorate recruitment over the years: 2026: 16 openings (up 240%), 2025: 7 openings (up 1400%), 2023: 7 openings (down 4%), 2022: 10 openings (up 1250%), 2021: 5 openings.

R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at 东莞东阳光药物研发有限公司? Based on an analysis of 's job postings over the past year, "计算机/网络/技术类" demand: 16%, "其他(研发和技术类)": 12.4%, "生物/制药/化工/环保类": 12.2%, "医疗卫生/美容保健类": 10%, "机械/仪器仪表类": 7.5%, "科研类": 5.2%. For reference only.

— What Are the Salaries Like? (829 records)

Manage
salary range: 6K - 50K, 67.7% of roles pay ¥10-30K
Note: salary statistics are based on 829 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 东莞东阳光药物研发有限公司?67.7% of positions earn 10-30K, Fresh graduate salary: ¥13.8K。Dongguan salary ranking top 15,经营管理类 average salary ¥27.7K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of

(More)
Are salaries high at 东莞东阳光药物研发有限公司? We provide: 销售,财务,运营,采购,研究员,bp,市场,招商,临床,产品经理,副总,医学经理,电气,研发工程师,材料研发,hr,大客户,质量,分析,项目经理. Click to view detailed salary analysis by job.

honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Related Industry Tags

Tags are auto-annotated by keyword text matching and may be correlated. For reference only.

Job Category

  • 经营管理类
    23.8% of total 23.8%
  • 销售类
    17.8% of total 17.8%
  • 计算机/网络/技术类
    15.9% of total 15.9%
  • 其他(研发和技术类)
    13% of total 13%

Education

  • 本科
    70.5% of total 70.5%
  • 硕士
    14% of total 14%
  • 大专
    11.7% of total 11.7%
  • 博士
    2.2% of total 2.2%

Experience

  • 3-5年
    33% of total 33%
  • 5-10年
    29.4% of total 29.4%
  • 1-3年
    18.4% of total 18.4%
  • 不限
    15.7% of total 15.7%
View Detailed Analysis

What does 东莞东阳光药物研发有限公司 require? Who is 东莞东阳光药物研发有限公司 hiring? recruitment: 经营管理类占比最多占23.8%,其次是销售类占17.8%. What education can get in at ? 本科占比最多占70.5%,其次是硕士占14%. High education required at ? 硕士占14%,博士占2.2%. Work experience required at ? 3-5年占比最多占33%,其次是5-10年占29.4%. Where are the job locations at ? 东莞占比最多占50.7%,其次是广州占11.7%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 11,549万(元)
Legal Representative: 唐新发
Date Established:
Credit Code: 914419007429578729
Registered Address: 广东省东莞市长安镇长安振安中路368号

Partners & Suppliers

委托康龙化成进行药物研发外包服务 Source
供应商 CRO药物研发服务
委托药明康德进行药物研发外包服务 Source
供应商 CRO药物研发服务
与华中科技大学在药物研发领域有合作项目 Source
供应商 高校科研合作
与广东医科大学建立产学研合作,共同进行药物研发 Source
供应商 高校科研合作

People who follow this company also follow

Competitors (Similar Companies)

“电子材料、新材料、新能源产业群”
“Large pharmaceutical enterprise group”
新药研发 胰岛素 心血管药 大健康
“Research, development, and production of anti-tumor and surgical medic”
“Create great products for users”
“To develop high-quality biologics that are accessible and affordable f”
“Top 100 Chinese Pharmaceutical Industry Enterprises”
“One of the leading enterprises in the pharmaceutical industry”
制药/药业 仿制药 化妆品 小分子药物
“Driving the high-quality development of China's digital economy and en”
物联网/IoT IT基础设施 服务外包 人力资源/HR外包
“提供一流的钴产品”
“One of the key backbone enterprises in China's machinery industry”
“Hyaluronic acid raw material supplier”
“National Key Leading Enterprise in Agricultural Industrialization”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates